Renal biopsy in liver transplant recipients

Nephrology Dialysis Transplantation

Volumn 24, Issue 7, 2009, Pages 2276-2282

  O'Riordan, Aisling ^a   Dutt, Neelanjana ^a   Cairns, Hugh ^a   Rela, Mohamed ^a   O'Grady, John G ^a   Heaton, Nigel ^a   Hendry, Bruce M ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Biopsy; Histology; Liver; Renal; Transplantation

Indexed keywords

ACUTE KIDNEY TUBULE NECROSIS; ADULT; ARTICLE; BLEEDING; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; FEMALE; GLOMERULONEPHRITIS; GRAFT RECIPIENT; HEMATURIA; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; KIDNEY FAILURE; LIVER TRANSPLANTATION; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; NEPHROSIS; NEPHROTOXICITY; PRIORITY JOURNAL; PROTEINURIA; RENOVASCULAR HYPERTENSION; SURVIVAL;

BIOPSY; FEMALE; HUMANS; KIDNEY; KIDNEY DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 67651102886     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp112     Document Type: Article

References (48)

1. Kim DY, Lim C, Parasuraman R et al. Renal disease burden following liver transplantation. Transplant Proc 2006; 38: 3663-3665
2. O'Riordan A, Wong V, McCormick PA et al. Chronic kidney disease post-liver transplantation. Nephrol Dial Transplant 2006; 21: 2630-2636
3. Ojo AO, Held PJ, Port FK et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349: 931-940
4. European FK506 Multicentre Liver Study Group. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. Lancet 1994; 344: 423-428
5. The U.S. Multicenter FK506 Liver Study Group. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994; 331: 1110-1115
6. Liptak P, Ivanyi B. Primer: histopathology of calcineurin-inhibitor toxicity in renal allografts. Nat Clin Pract Nephrol 2006; 2: 398-404
7. Davies DR, Bittmann I, Pardo J. Histopathology of calcineurin inhibitor-induced nephrotoxicity. Transplantation 2000; 69: SS11-SS13
8. Saliba F, Lakehal M, Pageaux GP et al. Risk factors for new-onset diabetes mellitus following liver transplantation and impact of hepatitis C infection: an observational multicenter study. Liver Transpl 2007; 13: 136-144
9. Textor SC, Taler SJ, Canzanello VJ et al. Posttransplantation hyper-tension related to calcineurin inhibitors. Liver Transpl 2000; 6: 521-530
10. Davis CL, Gonwa TA, Wilkinson AH. Pathophysiology of renal disease associated with liver disorders: implications for liver transplantation. Part I. Liver Transpl 2002; 8: 91-109
11. Wilkinson A, Pham PT. Kidney dysfunction in the recipients of liver transplants. Liver Transpl 2005; 11: S47-51
12. Kamar N, Izopet J, Alric L et al. Hepatitis C virus-related kidney disease: an overview. Clin Nephrol 2008; 69: 149-160
13. McGuire BM, Julian BA, Bynon JS Jr et al. Brief communication: Glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation. Ann Intern Med 2006; 144: 735-741
14. Dember LM. Amyloidosis-associated kidney disease. J Am Soc Nephrol 2006; 17: 3458-3471
15. Oguchi K, Takei Y, Ikeda S. Value of renal biopsy in the prognosis of liver transplantation in familial amyloid polyneuropathy ATTR Val30Met patients. Amyloid 2006; 13: 99-107
16. Axelsen RA, Crawford DH, Endre ZH et al. Renal glomerular lesions in unselected patients with cirrhosis undergoing orthotopic liver transplantation. Pathology 1995; 27: 237-246
17. Chin SE, Axelsen RA, Crawford DH et al. Glomerular abnormalities in children undergoing orthotopic liver transplantation. Pediatr Nephrol 1992; 6: 407-411
18. Crawford DH, Endre ZH, Axelsen RA et al. Universal occurrence of glomerular abnormalities in patients receiving liver transplants. Am J Kidney Dis 1992; 19: 339-344
19. Chandrakantan A, de Mattos AM, Naftel D et al. Increasing referral for renal transplant evaluation in recipients of nonrenal solid-organ transplants: a single-center experience. Clin J Am Soc Nephrol 2006; 1: 832-836
20. Chonchol M, Wachs M, Taylor J et al. Should we biopsy kidneys of patients post-liver transplant? Transplant Proc 2003; 35: 3035-3038
21. Levey AS, Bosch JP, Lewis JB et al. Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130: 461-470
22. Tomson CR. Indications for renal biopsy in chronic kidney disease. Clin Med 2003; 3: 513-517
23. Whittier WL, Korbet SM. Renal biopsy: update. Curr Opin Nephrol Hypertens 2004; 13: 661-665
24. Burden R, Tomson C. Identification, management and referral of adults with chronic kidney disease: concise guidelines. Clin Med 2005; 5: 635-642
25. Ojo AO. Renal disease in recipients of nonrenal solid organ transplantation. Semin Nephrol 2007; 27: 498-507
26. Jain A, Reyes J, Kashyap R et al. Long-term survival after liver transplantation in 4000 consecutive patients at a single center. Ann Surg 2000; 232: 490-500
27. Stratta P, Canavese C, Quaglia M et al. Posttransplantation chronic renal damage in nonrenal transplant recipients. Kidney Int 2005; 68: 1453-1463
28. Shihab FS. Cyclosporine nephropathy: pathophysiology and clinical impact. Semin Nephrol 1996; 16: 536-547
29. Pillebout E, Nochy D, Hill G et al. Renal histopathological lesions after orthotopic liver transplantation (OLT). Am J Transplant 2005; 5: 1120-1129
30. Lynn M, Abreo K, Zibari G et al. End-stage renal disease in liver transplants. Clin Transplant 2001; 15: 66-69
31. Neau-Cransac M, Morel D, Bernard PH et al. Renal failure after liver transplantation: outcome after calcineurin inhibitor withdrawal. Clin Transplant 2002; 16: 368-373
32. Fisher NC, Nightingale PG, Gunson BK et al. Chronic renal failure following liver transplantation: a retrospective analysis. Transplantation 1998; 66: 59-66
33. Dische FE, Neuberger J, Keating J et al. Kidney pathology in liver allograft recipients after long-term treatment with cyclosporin A. Lab Invest 1988; 58: 395-402
34. Snanoudj R, Durrbach A, Gauthier E et al. Changes in renal function in patients with familial amyloid polyneuropathy treated with orthotopic liver transplantation. Nephrol Dial Transplant 2004; 19: 1779-1785
35. Gonzalez-Michaca L, Chew-Wong A, Soltero L et al. Percutaneous kidney biopsy, analysis of 26 years: complication rate and risk factors. Comment. Rev Invest Clin 2000; 52: 125-131
36. Manno C, Strippoli GF, Arnesano L et al. Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy. Kidney Int 2004; 66: 1570-1577
37. Stratta P, Canavese C, Marengo M et al. Risk management of renal biopsy: 1387 cases over 30 years in a single centre. Eur J Clin Invest 2007; 37: 954-963
38. Jouet P, Meyrier A, Mal F et al. Transjugular renal biopsy in the treatment of patients with cirrhosis and renal abnormalities. Hepatology 1996; 24: 1143-1147
39. Meyrier A. Transjugular renal biopsy. Update on hepato-renal needlework. Nephrol Dial Transplant 2005; 20: 1299-1302
40. Cluzel P, Martinez F, Bellin MF et al. Transjugular versus percutaneous renal biopsy for the diagnosis of parenchymal disease: comparison of sampling effectiveness and complications. Radiology 2000; 215: 689-693
41. Kendrick EA, McVicar JP, Kowdley KV et al. Renal disease in hepatitis C-positive liver transplant recipients. Transplantation 1997; 63: 1287-1293
42. Davis CL, Gretch DR, Perkins JD et al. Hepatitis C-associated glomerular disease in liver transplant recipients. Liver Transpl Surg 1995; 1: 166-175
43. Abrahamian GA, Cosimi AB, Farrell ML et al. Prevalence of hepatitis C virus-associated mixed cryoglobulinemia after liver transplantation. Liver Transpl 2000; 6: 185-190
44. Fung J, Kelly D, Kadry Z et al. Immunosuppression in liver transplantation: beyond calcineurin inhibitors. Liver Transpl 2005; 11: 267-280
45. Fairbanks KD, Eustace JA, Fine D et al. Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus. Liver Transpl 2003; 9: 1079-1085
46. Watson CJ, Gimson AE, Alexander GJ et al. A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function. Liver Transpl 2007; 13: 1694-1702
47. Schlitt HJ, Barkmann A, Boker KH et al. Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study. Lancet 2001; 357: 587-591
48. Stewart SF, Hudson M, Talbot D et al. Mycophenolate mofetil monotherapy in liver transplantation. Lancet 2001; 357: 609-610